vs
MEDIFAST INC（MED）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
MEDIFAST INC的季度营收约是READING INTERNATIONAL INC的1.5倍（$75.1M vs $50.3M），READING INTERNATIONAL INC同比增速更快（-14.2% vs -36.9%），READING INTERNATIONAL INC自由现金流更多（$4.1M vs $-6.6M），过去两年READING INTERNATIONAL INC的营收复合增速更高（5.6% vs -34.4%）
迈德福斯特是一家总部位于美国马里兰州巴尔的摩的营养减重企业，该公司研发、分销并销售减重及健康相关产品，销售渠道涵盖官方网站、多层次营销、电话销售以及品牌加盟减重诊所。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
MED vs RDI — 直观对比
营收规模更大
MED
是对方的1.5倍
$50.3M
营收增速更快
RDI
高出22.7%
-36.9%
自由现金流更多
RDI
多$10.7M
$-6.6M
两年增速更快
RDI
近两年复合增速
-34.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.1M | $50.3M |
| 净利润 | — | $-2.6M |
| 毛利率 | 69.4% | — |
| 营业利润率 | -10.4% | -1.9% |
| 净利率 | — | -5.1% |
| 营收同比 | -36.9% | -14.2% |
| 净利润同比 | — | -14.5% |
| 每股收益（稀释后） | $-1.64 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MEDRDI
| Q4 25 | $75.1M | $50.3M | ||
| Q3 25 | $89.4M | $52.2M | ||
| Q2 25 | $105.6M | $60.4M | ||
| Q1 25 | $115.7M | $40.2M | ||
| Q4 24 | $119.0M | $58.6M | ||
| Q3 24 | $140.2M | $60.1M | ||
| Q2 24 | $168.6M | $46.8M | ||
| Q1 24 | $174.7M | $45.1M |
净利润MEDRDI
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $-2.3M | $-4.2M | ||
| Q2 25 | $2.5M | $-2.7M | ||
| Q1 25 | $-772.0K | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $1.1M | $-7.0M | ||
| Q2 24 | $-8.2M | $-12.8M | ||
| Q1 24 | $8.3M | $-13.2M |
毛利率MEDRDI
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 72.8% | — |
营业利润率MEDRDI
| Q4 25 | -10.4% | -1.9% | ||
| Q3 25 | -4.6% | -0.6% | ||
| Q2 25 | -1.0% | 4.8% | ||
| Q1 25 | -1.1% | -17.2% | ||
| Q4 24 | 0.6% | 2.6% | ||
| Q3 24 | 1.5% | -0.6% | ||
| Q2 24 | -4.7% | -16.4% | ||
| Q1 24 | 4.5% | -16.7% |
净利率MEDRDI
| Q4 25 | — | -5.1% | ||
| Q3 25 | -2.5% | -8.0% | ||
| Q2 25 | 2.3% | -4.4% | ||
| Q1 25 | -0.7% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | 0.8% | -11.7% | ||
| Q2 24 | -4.8% | -27.4% | ||
| Q1 24 | 4.8% | -29.4% |
每股收益（稀释后）MEDRDI
| Q4 25 | $-1.64 | $-0.11 | ||
| Q3 25 | $-0.21 | $-0.18 | ||
| Q2 25 | $0.22 | $-0.12 | ||
| Q1 25 | $-0.07 | $-0.21 | ||
| Q4 24 | $0.08 | $-0.11 | ||
| Q3 24 | $0.10 | $-0.31 | ||
| Q2 24 | $-0.75 | $-0.57 | ||
| Q1 24 | $0.76 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.3M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | $198.9M | $-18.2M |
| 总资产 | $248.0M | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资MEDRDI
| Q4 25 | $167.3M | $10.5M | ||
| Q3 25 | $173.5M | $8.1M | ||
| Q2 25 | $162.7M | $9.1M | ||
| Q1 25 | $164.6M | $5.9M | ||
| Q4 24 | $162.3M | $12.4M | ||
| Q3 24 | $170.0M | $10.1M | ||
| Q2 24 | $163.5M | $9.3M | ||
| Q1 24 | $156.4M | $7.5M |
总债务MEDRDI
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益MEDRDI
| Q4 25 | $198.9M | $-18.2M | ||
| Q3 25 | $214.7M | $-12.1M | ||
| Q2 25 | $216.0M | $-7.7M | ||
| Q1 25 | $211.0M | $-8.1M | ||
| Q4 24 | $210.1M | $-4.4M | ||
| Q3 24 | $207.3M | $1.6M | ||
| Q2 24 | $205.3M | $6.5M | ||
| Q1 24 | $211.0M | $18.0M |
总资产MEDRDI
| Q4 25 | $248.0M | $434.9M | ||
| Q3 25 | $268.2M | $435.2M | ||
| Q2 25 | $269.3M | $438.1M | ||
| Q1 25 | $280.0M | $441.0M | ||
| Q4 24 | $284.2M | $471.0M | ||
| Q3 24 | $291.2M | $495.7M | ||
| Q2 24 | $293.5M | $494.9M | ||
| Q1 24 | $302.8M | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-5.3M | $4.3M |
| 自由现金流经营现金流 - 资本支出 | $-6.6M | $4.1M |
| 自由现金流率自由现金流/营收 | -8.8% | 8.2% |
| 资本支出强度资本支出/营收 | 1.8% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $1.2M | $-2.9M |
8季度趋势，按日历期对齐
经营现金流MEDRDI
| Q4 25 | $-5.3M | $4.3M | ||
| Q3 25 | $12.1M | $295.0K | ||
| Q2 25 | $-3.4M | $1.6M | ||
| Q1 25 | $3.4M | $-7.7M | ||
| Q4 24 | $-4.9M | $8.0M | ||
| Q3 24 | $9.1M | $1.3M | ||
| Q2 24 | $13.1M | $-10.4M | ||
| Q1 24 | $7.3M | $-2.8M |
自由现金流MEDRDI
| Q4 25 | $-6.6M | $4.1M | ||
| Q3 25 | $10.8M | $-246.0K | ||
| Q2 25 | $-4.8M | $1.2M | ||
| Q1 25 | $1.9M | $-8.0M | ||
| Q4 24 | $-7.2M | $7.0M | ||
| Q3 24 | $7.7M | $-1.1M | ||
| Q2 24 | $11.1M | $-10.6M | ||
| Q1 24 | $5.4M | $-4.7M |
自由现金流率MEDRDI
| Q4 25 | -8.8% | 8.2% | ||
| Q3 25 | 12.0% | -0.5% | ||
| Q2 25 | -4.5% | 1.9% | ||
| Q1 25 | 1.6% | -19.8% | ||
| Q4 24 | -6.1% | 12.0% | ||
| Q3 24 | 5.5% | -1.8% | ||
| Q2 24 | 6.6% | -22.7% | ||
| Q1 24 | 3.1% | -10.4% |
资本支出强度MEDRDI
| Q4 25 | 1.8% | 0.3% | ||
| Q3 25 | 1.5% | 1.0% | ||
| Q2 25 | 1.3% | 0.6% | ||
| Q1 25 | 1.3% | 0.6% | ||
| Q4 24 | 1.9% | 1.7% | ||
| Q3 24 | 1.0% | 4.0% | ||
| Q2 24 | 1.1% | 0.5% | ||
| Q1 24 | 1.1% | 4.3% |
现金转化率MEDRDI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.36× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 8.04× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MED
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
